Penn Medicine Provider
Reproductive Endocrinology and Infertility
Anuja Dokras, MD, MHCI, PhD
4.8
(84)
Accepting new patients
Sees patients age 12 to 65
Penn Fertility Care
View 1 additional location

About me

  • Director, Penn Polycystic Ovary Syndrome Center
  • Executive Director, Women's Health Center for Clinical Innovation
  • Director, Penn Preimplantation Genetic Diagnosis Program
  • Medical Director, Reproductive Surgical Facility
  • Founder's Professor in Women's Health

I direct a multidisciplinary program for women with PCOS with access to nutritional, dermatological, weight management and psychological services. In addition, I direct the Women's Health Center for Clinical Innovation (WHCCI) that focuses on redesigning and reimagining healthcare delivery across the lifespan.

Education and training

  • Medical School: University of Mumbai (formerly Bombay)
  • Residency: University of Mumbai, Seth G.S. Medical College
  • Residency: Yale-New Haven Hospital
  • Fellowship: Yale-New Haven Hospital

What my patients think about me

Average Rating
4.8

87 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
good practice
February 2025
5.0
5.0
excellent service and patience
February 2025
5.0
5.0
i feel very comfortable and confident with dr dokras
February 2025
5.0
5.0
professional

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Dokras is a Penn Medicine physician.

Qualifications and experience

My research

Applebaum J, Kim EK, Sharp M, Dokras A, Shah DK. Racial and socioeconomic disparities in fertility treatment provision for patients with polycystic ovary syndrome. , Fertil Steril. , S0015-0282(24): 2024,00545-4


Lee IT, Rees J, King S, Kim A, Cherlin T, Hinkle S, Mumford SL, Dokras A. Depression, Anxiety, and Risk of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Longitudinal Study. , J Clin Endocrinol Metab. : 2024


Cooney LG, Sammel MD, Lee I, Clapp MA, Goldsammler M, Scott E, Bjorkman S, Fisher BT, Dokras A. The details matter: personalized prediction of live birth following in vitro fertilization in women with polycystic ovary syndrome. , Fertil Steril. , 121(6): 2024,1010-101


Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. , Nat Rev Dis Primers. , 10(1): 2024,27


Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, M Redman L, A Boyle J, Norman RJ, Mousa A, Joham AE Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. , Fertil Steril. , 120(4): 2023,767-793


Alur-Gupta S, Boland MR, Dokras A N3C Consortium Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome. , Fertil Steril. , 119(5): 2023,847-857


Senapati, S, Asch, D, Merchant, RM, Rosin, R, Seltzer, E, Mancheno, C, Dokras, A The Fast Track to Fertility Program: Rapid Cycle Innovation to Redesign Fertility Care , NEJM Catalyst Innovations in Care Delivery , 3(10): 2022


Alur-Gupta S, Boland MR, Dokras A; N3C Consortium Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome , Fertil Steril. , 119(2): 2023,847-857


Huddleston HG, Dokras A. Diagnosis and Treatment of Polycystic Ovary Syndrome. , JAMA. , 327(3): 2022,274-275


Dokras A. Does body weight affect cardiometabolic risk in women with polycystic ovary syndrome? , Fertil Steril, 111(1): 2019,56-57


View all publications